Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Jun 18:13:1558735.
doi: 10.3389/fbioe.2025.1558735. eCollection 2025.

Tissue nanotransfection and cellular reprogramming in regenerative medicine and antimicrobial dynamics

Affiliations
Review

Tissue nanotransfection and cellular reprogramming in regenerative medicine and antimicrobial dynamics

Mohammed Youssef Shakra. Front Bioeng Biotechnol. .

Abstract

Tissue nanotransfection (TNT) is a novel, non-viral nanotechnology platform that enables in vivo gene delivery and direct cellular reprogramming through localized nanoelectroporation. This review synthesizes current advancements in TNT, outlining its device architecture, electroporation principles, and optimized delivery of genetic cargo, including plasmid DNA, mRNA, and CRISPR/Cas9 components. The mechanisms underlying TNT-mediated cellular reprogramming are critically evaluated, including transcriptional activation, epigenetic remodeling, and metabolic shifts, across three major reprogramming strategies-induced pluripotency, direct lineage conversion, and partial cellular rejuvenation. TNT demonstrates transformative therapeutic potential in diverse biomedical applications, including tissue regeneration, ischemia repair, wound healing, immunotherapy, and antimicrobial therapy. This review highlights TNT's unique advantages over traditional gene delivery systems, namely, its high specificity, non-integrative approach, and minimal cytotoxicity, while also addressing existing limitations such as phenotypic stability and scalability. By integrating emerging data and identifying key translation challenges, this work positions TNT as a conceptual and technological advance in regenerative medicine and targeted gene therapy, offering a roadmap for future research and clinical implementation.

Keywords: antimicrobial; cellular reprogramming; regenerative medicine; tissue nanotransfection; wound healing.

PubMed Disclaimer

Conflict of interest statement

The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
Diagram of the structural components of a tissue nanotransfection (TNT) device. (a) TNT device. (b) Layer 1: The cargo (genetic material) reservoir. The genetic material to be delivered is often stored in a reservoir. (c) Layer 2: The nanotransfection chip typically contains microneedles. Each needle has a central hollow channel through which genetic material can be transferred.
FIGURE 2
FIGURE 2
The tissue nanotransfection technique produces cell membrane electroporation and introduces reprograming factors into diverse types of somatic cells to change their identity and phenotype. This technique has several medical applications, such as tissue regeneration and wound healing.

Similar articles

References

    1. Almeida M., Inácio J. M., Vital C. M., Rodrigues M. R., Araújo B. C., Belo J. A. (2025). Cell reprogramming, transdifferentiation, and dedifferentiation approaches for heart repair. Int. J. Mol. Sci. 26 (7), 3063. 10.3390/ijms26073063 - DOI - PMC - PubMed
    1. Alzate-Correa D., Lawrence W. R., Salazar-Puerta A., Higuita-Castro N., Gallego-Perez D. (2022). Nanotechnology-driven cell-based therapies in regenerative medicine. AAPS J. 24 (2), 43. 10.1208/s12248-022-00692-3 - DOI - PMC - PubMed
    1. Baddeley H. J. E., Isalan M. (2021). The application of CRISPR/Cas systems for antiviral therapy. Front. genome Ed. 3, 745559. 10.3389/fgeed.2021.745559 - DOI - PMC - PubMed
    1. Bae W., Ra E. A., Lee M. H. (2025). Epigenetic regulation of reprogramming and pluripotency: insights from histone modifications and their implications for cancer stem cell therapies. Front. cell Dev. Biol. 13, 1559183. 10.3389/fcell.2025.1559183 - DOI - PMC - PubMed
    1. Batista Napotnik T., Kos B., Jarm T., Miklavčič D., O'Connor R. P., Rems L. (2024). Genetically engineered HEK cells as a valuable tool for studying electroporation in excitable cells. Sci. Rep. 14 (1), 720. 10.1038/s41598-023-51073-5 - DOI - PMC - PubMed

LinkOut - more resources